Mercado Global de Hemostatos – Tendências do Setor e Previsão para 2029

Personalize o seu relatório Personalize o seu relatório Comprar agora Comprar agora Relatório de amostra grátis Relatório de amostra grátis
Casa Healthcare Global Hemostats Market
Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado Global de Hemostatos – Tendências do Setor e Previsão para 2029

  • Healthcare
  • Upcoming Reports
  • Jul 2022
  • Global
  • 350 Páginas
  • Número de tabelas: 220
  • Número de figuras: 60
Comprar agora Comprar agora

Global Hemostats Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Diagram Período de previsão
 2023 –2029
Diagram Tamanho do mercado (ano base )
 US$ MILHÕES
Pedido
Diagram Tamanho do mercado ( Ano de previsão)
 USD 28,902.90 Million
Diagram CAGR
 %
Diagram Principais participantes do mercado
  • CR Bard
  • B. Braun Melsungen AG
  • Baxter International
  • Integra LifeSciences
  • Marine Polymer Technologies

>Mercado Global de Hemostatos, por Tipo de Produto (Baseado em Trombina, Combinação, Baseado em Celulose Regenerada Oxidada, Baseado em Gelatina, Hemostato Baseado em Colagénio), Formulação (Hemostatos de Matriz e Gel, Hemostatos de Folha e Almofada, Hemostatos de Esponja, Hemostatos em Pó), Aplicação (Ortopédico, Cirurgia Geral, Cirurgia Neurológica, Cirurgia Cardiovascular, Cirurgia Reconstrutiva, Cirurgia Ginecológica), Indicação (fecho de feridas, cirurgia), utilizador final (hospitais, clínicas, centros de ambulatório, cuidados de saúde comunitários, outros ), - Tendências do setor e previsão para 2029

Mercado de hemostatos

Análise e dimensão do mercado

A perda de sangue ocorre durante a cirurgia, como resultado da rutura dos vasos sanguíneos. Para evitar a perda excessiva de sangue, é fundamental coagular o sangue. A hemostasia refere-se à formação de coágulos sanguíneos no local da lesão. Os hemostatos são ferramentas cirúrgicas utilizadas para controlar a hemorragia do paciente durante a cirurgia. Estes dispositivos auxiliam na formação de coágulos sanguíneos temporários para controlar a hemorragia. É fundamental, no entanto, que a utilização destas ferramentas seja localizada e estritamente regulamentada.

A Data Bridge Market Research analisa que o mercado dos hemostatos deverá atingir o valor de 4,65 mil milhões de dólares até ao ano de 2029, com um CAGR de 6,85% no período de previsão. O mercado dos hemostatos está a ser impulsionado pelo aumento do número de procedimentos cirúrgicos.

Definição de mercado

Um hemostato é uma ferramenta cirúrgica utilizada para controlar a perda de sangue ou parar hemorragias durante uma cirurgia de grande porte. Essencialmente, é utilizado nas fases iniciais da cirurgia para uma incisão inicial que fecha os vasos sanguíneos até que estes sejam ligados. Inclui uma variedade de instrumentos, como porta-agulhas, pivôs, pinças e pinças.

Métrica de reporte

Detalhes

Período de previsão

2022 a 2029

Ano base

2021

Anos históricos

2020 (personalizável para 2014 - 2019)

Unidades Quantitativas

Receita em milhões de dólares, volumes em unidades, preços em dólares

Segmentos cobertos

Tipo de produto (à base de trombina, combinação, à base de celulose regenerada oxidada, à base de gelatina, hemostático à base de colagénio), formulação (hemostatos de matriz e gel, hemostáticos de folha e almofada, hemostáticos de esponja, hemostáticos em pó), aplicação (ortopédica, cirurgia geral, cirurgia neurológica, Cirurgia Cardiovascular, Cirurgia Reconstrutiva, Cirurgia Ginecológica), Indicação (Fecho de Feridas, Cirurgia), Utilizador Final (Hospitais, Clínicas, Centros de Ambulatório, Saúde Comunitária, Outros)

Países abrangidos

EUA, Canadá e México na América do Norte, Alemanha, França, Reino Unido, Holanda, Suíça, Bélgica, Rússia, Itália, Espanha, Turquia, Resto da Europa na Europa, China, Japão, Índia, Coreia do Sul, Singapura, Malásia , Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia-Pacífico (APAC), Arábia Saudita, Emirados Árabes Unidos, África do Sul, Egito, Israel, Resto do Médio Oriente e África (MEA) como parte do Médio Oriente e África (MEA), Brasil, Argentina e Resto da América do Sul como parte da América do Sul.

Participantes do mercado abrangidos

CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).

Hemostats Market Dynamics

Drivers

  • The rise in the surgical procedures

Increasing the number of surgical procedures is a critical factor driving market growth, as is an increase in the number of regulatory approvals, an increase in the incidence of sports-related injuries and spinal ailments, and an increase in the focus on effective blood loss management in patients during surgeries, among other factors driving the hemostats market.

The increase in the research and development activities and growing awareness

Rising R&D activities in the market, an increase in the number of hospitals & surgical centres, and an increase in emerging markets will all create new opportunities for the hemostats market during the forecasted period.

  • Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the hemostats market.

Restraints/Challenges

The scarcity of skilled professionals and trained expertise will be a major impediment to the growth of the hemostats market. Medication costs will also slow the market's growth rate. Inadequate reimbursement policies will also limit the scope of growth.

This hemostats market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hemostats market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Hemostats Market

With the World Health Organization officially declaring the COVID-19 outbreak a pandemic, a coalition of established pharmaceutical and biopharmaceutical companies, as well as small startups, has stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. The COVID-19 outbreak has had a significant impact on the availability of hospital resources around the world. This has primarily been addressed by drastically reducing inpatient and outpatient services for other diseases, as well as implementing infection prevention and control measures. With the pandemic affecting countries all over the world, the number of surgical procedures has plummeted precipitously.

Global Hemostats Market Scope

The hemostats market is segmented on the basis product type, formulation, application, indication and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product type                                                                      

  • Combination
  • Oxidized regenerated cellulose based
  • Gelatine based
  • Collagen based haemostat

On the basis of product type, the hemostats market is segmented into thrombin based, combination, oxidized regenerated cellulose based, gelatin based and collagen based hemostat.

Formulation

  • Matrix and gel hemostats
  • Sheet and pad hemostats
  • Sponge hemostats
  • Powder hemostats

Based on formulation, the hemostats market is segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats and powder hemostats.

Application

  • Orthopaedic
  • General surgery
  • Neurological surgery
  • Cardiovascular surgery
  • Reconstructive surgery
  • Gynaecological surgery

Based on application, the hemostats market is segmented into orthopedic, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery and gynecological surgery.

Indication

  • Closure
  • Surgery

Based on indication, the hemostats market is segmented into wound closure and surgery.

End User

  • Ambulatory centers
  • Hospitals
  • Clinics
  • Community healthcare
  • Others

The hemostats market is also segmented on the basis of end-user into hospitals, clinics, ambulatory centers, community healthcare and others.

Hemostats Market Regional Analysis/Insights

The hemostats market is analysed and market size insights and trends are provided by country, product type, formulation, application, indication and end-user as referenced above.

Os países abrangidos no relatório de mercado dos hemostatos são os EUA, Canadá e México na América do Norte, Alemanha, França, Reino Unido, Holanda, Suíça, Bélgica, Rússia, Itália, Espanha, Turquia, Resto da Europa na Europa, China, Japão, Índia, Coreia do Sul, Singapura, Malásia, Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia-Pacífico (APAC), Arábia Saudita, Emirados Árabes Unidos, África do Sul, Egito, Israel, Resto do Médio Oriente e África (MEA) como parte do Médio Oriente e África (MEA), Brasil, Argentina e Resto da América do Sul como parte da América do Sul.

A Ásia-Pacífico domina o mercado das pinças hemostáticas devido ao aumento do número de cirurgias realizadas na região, bem como ao desenvolvimento de produtos tecnologicamente avançados para alcançar o controlo do sangue durante procedimentos relacionados com traumas.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.    

Crescimento da infraestrutura de saúde Base instalada e penetração de novas tecnologias

O mercado de hemostatos também fornece análises de mercado detalhadas para o crescimento de cada país em termos de despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado de hemostatos, impacto da tecnologia utilizando curvas de linha de vida e alterações nos cenários regulatórios de saúde e o seu impacto no mercado dos hemostatos. Os dados estão disponíveis para o período histórico 2010-2020.

Análise do cenário competitivo e da quota de mercado dos hemostatos

O panorama competitivo do mercado de hemostatos fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado dos hemostatos.

Alguns dos principais players que operam no mercado dos hemostatos são

  • CR Bard, Inc.
  • B. Braun Melsungen AG (Alemanha)
  • (EUA)
  • Integra LifeSciences (EUA)
  • Marine Polymer Technologies, Inc.
  • Teleflex (EUA)
  • Ethicon, Inc.
  • (EUA)
  • Z-Medica LLC (EUA)
  • Gelita Medical GmbH (Alemanha)
  • Anika Therapeutics, Inc.
  • Stryker (EUA)
  • Integra Lifesciences Corporation (EUA).

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Sample Image Click on image to enlarge
  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

TABLE OF CONTENTS :

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY 1.2. MARKET DEFINITION 1.3. OVERVIEW OF GLOBAL HEMOSTATS MARKET 1.4. CURRENCY AND PRICING 1.5. LIMITATION 1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCE 2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. CHRONIC CONDITIONS AND AGING POPULATION LEADING TO INCREASE IN NUMBER OF SURGICAL PROCEDURES 3.1.2. TECHNOLOGICAL ADVANCEMENTS 3.1.3. INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES 3.1.4. IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING HEALTHCARE SPENDING

3.2. RESTRAINTS

3.2.1. RELUCTANCE OF SURGEONS TOWARDS NEW PRODUCTS 3.2.2. WEAK REIMBURSEMENT

3.3. OPPORTUNITIES

3.3.1. UNMET MEDICAL NEEDS 3.3.2. EMERGING MARKET

3.4. CHALLENGES

3.4.1. DEVELOPMENT OF SUBSTITUTE PRODUCTS 3.4.2. LIMITATIONS OF HEMOSTATIC AGENTS IN ACHIEVING HEMOSTASIS

4. PREMIUM INSIGHTS 5. REGULATORY

5.1. OVERVIEW 5.2. REGULATORY PROCEDURE

6. REIMBURSEMENT

6.1. OVERVIEW 6.2. REIMBURSEMENT SCENARIO

7. EXECUTIVE SUMMARY 8. GLOBAL HEMOSTATS MARKET, BY TYPE

8.1. OVERVIEW 8.2. THROMBIN BASED HEMOSTATS 8.3. COMBINATION AGENT HEMOSTATS 8.4. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS 8.5. GELATIN BASED HEMOSTATS 8.6. COLLAGEN BASED HEMOSTATS

9. GLOBAL HEMOSTATS MARKET,BY APPLICATION

9.1. OVERVIEW 9.2. GLOBAL HEMOSTATS MARKET, BY APPLICATION 9.3. WOUND CLOSURE 9.4. SURGICAL HEMOSTATS

10. GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL

10.1. OVERVIEW 10.1.1. DIRECT TENDERS 10.1.2. RETAIL

11. GLOBAL HEMOSTATS MARKET, BY END USER

11.1. OVERVIEW 11.2. HOSPITALS 11.3. AMBULATORY CENTERS 11.4. COMMUNITY HEALTHCARE 11.5. CLINICS

12. GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY

12.1. OVERVIEW

12.2. NORTH AMERICA

12.2.1. U.S. 12.2.2. CANADA 12.2.3. MEXICO

12.3. EUROPE

12.3.1. GERMANY 12.3.2. FRANCE 12.3.3. U.K. 12.3.4. ITALY 12.3.5. SPAIN 12.3.6. RUSSIA 12.3.7. TURKEY 12.3.8. BELGIUM 12.3.9. NETHERLANDS 12.3.10. SWITZERLAND 12.3.11. REST OF EUROPE

12.4. ASIA-PACIFIC (APAC)

12.4.1. JAPAN 12.4.2. CHINA 12.4.3. SOUTH KOREA 12.4.4. INDIA 12.4.5. AUSTRALIA 12.4.6. SINGAPORE 12.4.7. THAILAND 12.4.8. MALAYSIA 12.4.9. INDONESIA 12.4.10. PHILIPPINES 12.4.11. REST OF APAC

12.5. SOUTH AMERICA

12.5.1. BRAZIL 12.5.2. REST OF SOUTH AMERICA

12.6. MEA

12.6.1. SOUTH AFRICA 12.6.2. REST OF MEA

13. GLOBAL HEMOSTATS MARKET, COMPANY LANDSCAPE

13.1. COMPANY SHARE ANALYSIS: GLOBAL 13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA 13.3. COMPANY SHARE ANALYSIS: EUROPE 13.4. COMPANY SHARE ANALYSIS: APAC

14. COMPANY PROFILES

14.1. ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC)

14.1.1. COMPANY OVERVIEW 14.1.2. REVENUE ANALYSIS 14.1.3. PRODUCT PORTFOLIO 14.1.4. RECENT DEVELOPMENTS

14.2. PFIZER

14.2.1. COMPANY OVERVIEW 14.2.2. REVENUE ANALYSIS 14.2.3. PRODUCT PORTFOLIO 14.2.4. RECENT DEVELOPMENTS

14.3. C.R BARD

14.3.1. COMPANY OVERVIEW 14.3.2. REVENUE ANALYSIS 14.3.3. PRODUCT PORTFOLIO 14.3.4. RECENT DEVELOPMENTS

14.4. BAXTER

14.4.1. COMPANY OVERVIEW 14.4.2. REVENUE ANALYSIS 14.4.3. PRODUCT PORTFOLIO 14.4.4. RECENT DEVELOPMENTS

14.5. VASCULAR SOLUTIONS, INC (ACQUIRED BY TELEFLEX INCORPORATED)

14.5.1. COMPANY OVERVIEW 14.5.2. REVENUE ANALYSIS 14.5.3. PRODUCT PORTFOLIO 14.5.4. RECENT DEVELOPMENTS

14.6. B.BRAUN MELSUNGEN AG

14.6.1. COMPANY OVERVIEW 14.6.2. REVENUE ANALYSIS 14.6.3. PRODUCT PORTFOLIO 14.6.4. RECENT DEVELOPMENTS

14.7. 3-D MATRIX LTD

14.7.1. COMPANY OVERVIEW 14.7.2. REVENUE ANALYSIS 14.7.3. PRODUCT PORTFOLIO 14.7.4. RECENT DEVELOPMENTS

14.8. RESORBA MEDICAL GMBH

14.8.1. COMPANY OVERVIEW 14.8.2. REVENUE ANALYSIS 14.8.3. PRODUCT PORTFOLIO 14.8.4. RECENT DEVELOPMENTS

14.9. ANIKA THERAPEUTICS, INC.

14.9.1. COMPANY OVERVIEW 14.9.2. REVENUE ANALYSIS 14.9.3. PRODUCT PORTFOLIO 14.9.4. RECENT DEVELOPMENTS

14.10. BIOM’UP

14.10.1. COMPANY OVERVIEW 14.10.2. REVENUE ANALYSIS 14.10.3. PRODUCT PORTFOLIO 14.10.4. RECENT DEVELOPMENTS

14.11. CRYOLIFE, INC.

14.11.1. COMPANY OVERVIEW 14.11.2. REVENUE ANALYSIS 14.11.3. PRODUCT PORTFOLIO 14.11.4. RECENT DEVELOPMENTS

14.12. EQUIMEDICAL

14.12.1. COMPANY OVERVIEW 14.12.2. REVENUE ANALYSIS 14.12.3. PRODUCT PORTFOLIO 14.12.4. RECENT DEVELOPMENTS

14.13. HEMOSTASIS, LLC

14.13.1. COMPANY OVERVIEW 14.13.2. REVENUE ANALYSIS 14.13.3. PRODUCT PORTFOLIO 14.13.4. RECENT DEVELOPMENTS

14.14. MEDTRADE PRODUCTS LIMITED

14.14.1. COMPANY OVERVIEW 14.14.2. REVENUE ANALYSIS 14.14.3. PRODUCT PORTFOLIO 14.14.4. RECENT DEVELOPMENTS

14.15. STRYKER

14.15.1. COMPANY OVERVIEW 14.15.2. REVENUE ANALYSIS 14.15.3. PRODUCT PORTFOLIO 14.15.4. RECENT DEVELOPMENTS

14.16. ARCH THERAPEUTICS, INC.

14.16.1. COMPANY OVERVIEW 14.16.2. REVENUE ANALYSIS 14.16.3. PRODUCT PORTFOLIO 14.16.4. RECENT DEVELOPMENTS

14.17. INTEGRA LIFESCIENCES CORPORATION

14.17.1. COMPANY OVERVIEW 14.17.2. REVENUE ANALYSIS 14.17.3. PRODUCT PORTFOLIO 14.17.4. RECENT DEVELOPMENTS

14.18. ALTAYLAR MEDICAL

14.18.1. COMPANY OVERVIEW 14.18.2. REVENUE ANALYSIS 14.18.3. PRODUCT PORTFOLIO 14.18.4. RECENT DEVELOPMENTS

14.19. BIOCER ENTWICKLUNGS-GMBH

14.19.1. COMPANY OVERVIEW 14.19.2. REVENUE ANALYSIS 14.19.3. PRODUCT PORTFOLIO 14.19.4. RECENT DEVELOPMENTS

14.20. SMI (STARCH MEDICAL)

14.20.1. COMPANY OVERVIEW 14.20.2. REVENUE ANALYSIS 14.20.3. PRODUCT PORTFOLIO 14.20.4. RECENT DEVELOPMENTS

15. RELATED REPORTS

Lista de Tabela

LIST OF TABLE :

TABLE 1 HEALTHCARE EXPENDITURES OF VARIOUS COUNTRIES TABLE 2 ABSORBABLE HEMOSTATIC AGENTS APPROVED THROUGH PMA OR NDA* TABLE 3 GLOBAL HEMOSTATS MARKET, BY PRODUCT TYPE, BY REGION 2015– 2024 (USD MILLION) TABLE 4 GLOBAL HEMOSTATS MARKET, BY TYPE, 2015 – 2024(USD MILLION) TABLE 5 GLOBAL HEMOSTATS MARKET, THROMBIN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 6 GLOBAL HEMOSTATS MARKET, COMBINATION AGENT, BY REGION 2015– 2024 (USD MILLION) TABLE 7 GLOBAL HEMOSTATS MARKET, OXIDIZED REGENERATED CELLULOSE BASED, BY REGION, 2015– 2024 (USD MILLION) TABLE 8 GLOBAL HEMOSTATS MARKET, GELATIN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 9 GLOBAL HEMOSTATS MARKET, COLLAGEN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 10 GLOBAL HEMOSTATS APPLICATION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 11 WOUND CLOSURE, BY APPLICATION, BY REGION, 2015 – 2024 (USD MILLION) TABLE 12 SURGICAL HEMOSTATS, BY APPLICATION, BY REGION, 2015 – 2024 (USD MILLION) TABLE 13 GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 14 GLOBAL HEMOSTATS MARKET, DIRECT TENDERS, BY REGION, 2015 – 2024 (USD MILLION) TABLE 15 GLOBAL HEMOSTATS MARKET, RETAIL, BY REGION, 2015 – 2024 (USD MILLION) TABLE 16 GLOBAL HEMOSTATS MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 17 GLOBAL HEMOSTATS MARKET, HOSPITALS, BY REGION 2015– 2024 (USD MILLION) TABLE 18 GLOBAL HEMOSTATS MARKET, AMBULATORY CENTERS, BY REGION 2015– 2024 (USD MILLION) TABLE 19 GLOBAL HEMOSTATS MARKET, COMMUNITY HEALTHCARE, BY REGION 2015– 2024 (USD MILLION) TABLE 20 GLOBAL HEMOSTATS MARKET, CLINICS, BY REGION 2015– 2024 (USD MILLION) TABLE 21 GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION) TABLE 22 NORTH AMERICA HEMOSTATSMARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 23 NORTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 26 NORTH AMERICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 27 U.S. HEMOSTATS MARKET, BY PRODUCT TYPE ,2015 – 2024 (USD MILLION) TABLE 28 U.S. HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 29 U.S.HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 30 U.S. HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 31 CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 32 CANADA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 33 CANADA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 34 CANADA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 35 MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 36 MEXICO HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 37 MEXICO HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 38 MEXICO HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 39 EUROPE HEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 40 EUROPEHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 41 EUROPE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 42 EUROPE HEMOSTATS MARKET, BY END USER,2015 – 2024 (USD MILLION) TABLE 43 EUROPE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 44 GERMANYHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 45 GERMANY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 46 GERMANY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 47 GERMANY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 48 FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 49 FRANCE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 50 FRANCE HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 51 FRANCE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 52 U.K. HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 53 U.K. HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 54 U.K. HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 55 U.K. HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 56 ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 57 ITALY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 58 ITALY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 59 ITALY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 60 SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 61 SPAIN HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 62 SPAIN HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 63 SPAIN HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 64 RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 65 RUSSIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 66 RUSSIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 67 RUSSIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 68 TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 69 TURKEY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 70 TURKEY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 71 TURKEY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 72 BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 73 BELGIUM HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 74 BELGIUM HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 75 BELGIUM HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 76 NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 77 NETHERLANDS HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 78 NETHERLANDS HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 79 NETHERLANDS HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 80 SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 81 SWITZERLAND HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 82 SWITZERLAND HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 83 SWITZERLAND HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 84 REST OF EUROPE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 85 APAC HEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 86 APAC HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 87 APAC HEMOSTATS MARKET, BY APPLICATION,2015 – 2024 (USD MILLION) TABLE 88 APAC HEMOSTATS MARKET, BY END USER,2015 – 2024 (USD MILLION) TABLE 89 APAC HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 90 JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 91 JAPAN HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 92 JAPAN HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 93 JAPAN HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 94 CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 95 CHINA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 96 CHINA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 97 CHINA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 98 SOUTH KOREAHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 99 SOUTH KOREA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 100 SOUTH KOREA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 101 SOUTH KOREA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 102 INDIA HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 103 INDIA HEMOSTATS MARKET, BY APPLICATION,2015 – 2024 (USD MILLION) TABLE 104 INDIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 105 INDIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 106 AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 107 AUSTRALIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 108 AUSTRALIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 109 AUSTRALIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 110 SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 111 SINGAPORE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 112 SINGAPORE HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 113 SINGAPORE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 114 THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 115 THAILAND HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 116 THAILAND HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 117 THAILAND HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 118 MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 119 MALAYSIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 120 MALAYSIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 121 MALAYSIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 122 INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 123 INDONESIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 124 INDONESIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 125 INDONESIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 126 PHILIPPINES HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 127 PHILIPPINES HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 128 PHILIPPINES HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 129 PHILIPPINES HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 130 REST OF APACHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 131 SOUTH AMERICAHEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 132 SOUTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 133 SOUTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 134 SOUTH AMERICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 135 SOUTH AMERICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 136 BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 137 BRAZIL HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 138 BRAZIL HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 139 BRAZIL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 140 REST OF SOUTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 141 MEA HEMOSTATS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 142 MEA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 143 MEA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 144 MEA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 145 MEA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 146 SOUTH AFRICAHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 147 SOUTH AFRICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 148 SOUTH AFRICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 149 SOUTH AFRICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 150 REST OF MEA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

Lista de Figura

LIST OF FIGURES

FIGURE 1 GLOBAL HEMOSTATS MARKET: SEGMENTATION FIGURE 2 GLOBAL HEMOSTATS MARKET: GEOGRAPHIC SCOPE FIGURE 3 GLOBAL HEMOSTATS MARKET: DATA TRIANGULATION FIGURE 4 GLOBAL HEMOSTATS MARKET RESEARCH SNAPSHOT FIGURE 5 GLOBAL HEMOSTATS MARKET BOTTOM UP APPROACH FIGURE 6 GLOBAL HEMOSTATS MARKET TOP DOWN APPROACH FIGURE 7 GLOBAL HEMOSTATS MARKET: INTERVIEW DEMOGRAPHICS FIGURE 8 MEDICAL ADVANCEMENTS AND INCREASE IN HEMORRAGE CASES ARE EXPECTED TO DRIVE THE MARKET FOR HEMOSTATS IN THE FORECAST PERIOD 2017 TO 2024 FIGURE 9 THROMBIN BASED HEMOSTATS MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMOSTATS MARKET IN 2017 & 2024 FIGURE 10 ASIA PACIFIC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR HEMOSTATS MANUFACTURERS IN THE FORECAST PERIOD TO 2024 FIGURE 11 GLOBAL HEMOSTATS MARKET: SEGMENTATION FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR HEMOSTATS AND APAC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024 FIGURE 13 GLOBAL HEMOSTATS MARKET: BY TYPE, SNAPSHOT 2016 FIGURE 14 GLOBAL THROMBIN BASED HEMOSTATS MARKET: BY REGION FIGURE 15 GLOBAL COMBINATION AGENT HEMOSTATS MARKET: BY REGION FIGURE 16 GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET: BY REGION FIGURE 17 GLOBAL GELATIN BASED HEMOSTATS MARKET: BY REGION FIGURE 18 GLOBAL COLLAGEN BASED HEMOSTATS MARKET: BY REGION FIGURE 19 GLOBAL HEMOSTATS MARKET: BY APPLICATION, SNAPSHOT 2016 FIGURE 20 GLOBAL HEMOSTATS MARKET: WOUND CLOSURE, BY REGION FIGURE 21 GLOBAL HEMOSTATS MARKET: SURGERIES, BY REGION FIGURE 22 GLOBAL HEMOSTATS MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016 FIGURE 23 GLOBAL HEMOSTATS MARKET: DIRECT TENDERS, BY REGION FIGURE 24 GLOBAL HEMOSTATS MARKET: RETAIL, BY REGION FIGURE 25 GLOBAL HEMOSTATS MARKET DOMINATED BY HOSPITALS FIGURE 26 GLOBAL HEMOSTATS MARKET:BY END-USER, SNAPSHOT 2016 FIGURE 27 GLOBAL HEMOSTATS MARKET: HOSPITALS; BY REGION FIGURE 28 GLOBAL HEMOSTATS MARKET: AMBULATORY CENTERS; BY REGION FIGURE 29 GLOBAL HEMOSTATS MARKET: COMMUNITY HEALTHCARE; BY REGION FIGURE 30 GLOBAL HEMOSTATS MARKET: CLINICS; BY REGION FIGURE 31 GLOBAL HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 32 GLOBAL HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 33 GLOBAL HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 34 GLOBAL HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 35 GLOBAL HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 36 NORTH AMERICA HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 37 NORTH AMERICA HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 38 NORTH AMERICA HEMOSTATSMARKET :BY COUNTRY (2017) FIGURE 39 NORTH AMERICA HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 40 NORTH AMERICA HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024 FIGURE 41 EUROPE HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 42 EUROPE HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 43 EUROPE HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 44 EUROPE HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 45 EUROPE HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 46 APAC HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 47 APAC HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 48 APAC HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 49 APAC HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 50 APAC HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 51 SOUTH AMERICAHEMOSTATS MARKET SNAPSHOT (2017) FIGURE 52 SOUTH AMERICA HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 53 SOUTH AMERICA HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 54 SOUTH AMERICAHEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 55 SOUTH AMERICAHEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 56 MEA HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 57 MEA HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 58 MEA HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 59 MEA HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 60 MEA HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 61 GLOBAL HEMOSTATS MARKET: COMPANY SHARE 2016 (%) FIGURE 62 NORTH AMERICA HEMOSTATS MARKET: COMPANY SHARE 2016 (%) FIGURE 63 EUROPE HEMOSTATS MARKET: COMPANY SHARE 2016 (%) FIGURE 64 APAC HEMOSTATS MARKET: COMPANY SHARE 2016 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The market is segmented based on , By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery), Indication (Wound Closure, Surgery), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), – Industry Trends and Forecast to 2029 .
The Global Hemostats Market size was valued at USD 0.00 USD Million in 2022.
The Global Hemostats Market is projected to grow at a CAGR of 6.85% during the forecast period of 2023 to 2029.
The major players operating in the market include , CR Bard , B. Braun Melsungen AG , Baxter International , Integra LifeSciences , Marine Polymer Technologies , Teleflex , Ethicon , Pfizer , Z,Medica LLC , Gelita Medical GmbH , Anika Therapeutics , Stryker , Integra Lifesciences Corporation ,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..

Navegue pelas páginas relacionadas

Banner